Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$9.87B Buy
79,117,664
+14,623,673
+23% +$1.74B 0.14% 112
2025
Q3
$7.73B Buy
64,493,991
+88,925
+0.1% +$9.39M 0.12% 147
2025
Q2
$5.91B Buy
64,405,066
+649,598
+1% +$59.3M 0.1% 193
2025
Q1
$5.61B Buy
63,755,468
+24,591,538
+63% +$2.42B 0.1% 185
2024
Q4
$3.62B Buy
39,163,930
+145,101
+0.4% +$14M 0.06% 299
2024
Q3
$3.59B Buy
39,018,829
+111,830
+0.3% +$9.39M 0.06% 302
2024
Q2
$2.92B Buy
38,906,999
+12,130,636
+45% +$968M 0.06% 334
2024
Q1
$2.31B Sell
26,776,363
-252,595
-0.9% -$19.3M 0.05% 404
2023
Q4
$1.87B Sell
27,028,958
-102,431
-0.4% -$6.18M 0.04% 446
2023
Q3
$1.48B Buy
+27,131,389
New +$1.54B 0.04% 480

Other funds holding CRH

Vanguard Group's CRH Position: Q4 2025 in Review

Vanguard Group increased its CRH (CRH) stake by 23% in Q4 2025, buying an estimated $1.74B and bringing the position to 79,117,664 shares worth $9.87B. The position accounts for 0.14% of the portfolio, ranked #112.

Vanguard Group first reported a position in CRH in Q3 2023 and has held it in 10 quarters since. 1,010 funds tracked by Wall St. Rank hold CRH as of Q4 2025.

  • Vanguard Group held 79,117,664 shares of CRH worth $9.87B as of Q4 2025.
  • Vanguard Group bought 14,623,673 CRH shares in Q4 2025, an estimated $1.74B.
  • CRH made up 0.14% of Vanguard Group's portfolio in Q4 2025, its #112 holding.
  • Vanguard Group first reported a position in CRH in Q3 2023 and has held it in 10 quarters since.
  • 1,010 funds tracked by Wall St. Rank held CRH as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.